Immuron ceo, steven lydeamore to present at the emerging growth conference

Melbourne, australia, aug. 15, 2024 (globe newswire) -- immuron limited (asx: imc; nasdaq: imrn), an australian based and globally integrated biopharmaceutical company is pleased to announce that our chief executive officer, steven lydeamore has been invited to present at the emerging growth conference on august 22nd, 2024.
IMRN Ratings Summary
IMRN Quant Ranking